Translocase of the outer mitochondrial membrane complex (TOMM complex)

The Translocase of the Outer Mitochondrial Membrane (TOMM) complex is the primary gateway for the entry of nuclear-encoded proteins into the mitochondria, a process essential for mitochondrial biogenesis and cellular energy production (Source: UniProt P26358). It is a multi-subunit assembly consisting of the pore-forming channel TOMM40 and several receptor subunits, such as TOMM20, TOMM22, and TOMM70, which recognize and bind mitochondrial targeting signals on precursor proteins (Source: PubMed 31435016). In neurodegenerative diseases like Parkinson's, the TOMM complex is crucial for the PINK1/Parkin-mediated mitophagy pathway, where it serves as a platform for PINK1 stabilization on damaged mitochondria (Source: PubMed 24658251). Furthermore, genetic polymorphisms in the TOMM40 gene, specifically poly-T repeats, are strongly associated with the age of onset and risk of Alzheimer's disease (Source: PubMed 21148225). In the context of oncology, the upregulation of TOMM subunits like TOMM20 is observed in various high-grade tumors to meet increased metabolic demands, making it a potential target for metabolic-based therapies (Source: PubMed 28655771). While direct pharmacological modulators are currently limited to experimental compounds, the complex represents a significant focal point for therapeutic strategies aimed at correcting mitochondrial dysfunction or inducing selective cell death in cancer.

Other names

TOM complexTranslocase of the outer membraneMitochondrial outer membrane translocaseTOMM40-TOMM20 complex

Modulation of mitochondrial protein translocation and regulation of mitophagy (Source: PubMed 32814890).